Thursday, November 28, 2024
- Advertisement -spot_img

TAG

the National Healthcare Security Administration

AstraZeneca’s Enhertu included in China’s state insurance reimbursement

SHANGHAI (Reuters) - AstraZeneca's blockbuster breast cancer drug will be added to China's national reimbursement scheme list, according to an...

Latest news

- Advertisement -spot_img